These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16997555)

  • 1. Hydroxyl radical scavenging by edaravone derivatives: Efficient scavenging by 3-methyl-1-(pyridin-2-yl)-5-pyrazolone with an intramolecular base.
    Nakagawa H; Ohyama R; Kimata A; Suzuki T; Miyata N
    Bioorg Med Chem Lett; 2006 Dec; 16(23):5939-42. PubMed ID: 16997555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scavenging activity of aminoantipyrines against hydroxyl radical.
    Santos PM; Antunes AM; Noronha J; Fernandes E; Vieira AJ
    Eur J Med Chem; 2010 Jun; 45(6):2258-64. PubMed ID: 20172632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reaction rate of edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186)) with hydroxyl radical.
    Abe S; Kirima K; Tsuchiya K; Okamoto M; Hasegawa T; Houchi H; Yoshizumi M; Tamaki T
    Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):186-91. PubMed ID: 14758002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OH radical scavenging activity of Edaravone: mechanism and kinetics.
    Pérez-González A; Galano A
    J Phys Chem B; 2011 Feb; 115(5):1306-14. PubMed ID: 21190324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulse radiolysis study on free radical scavenger edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one).
    Lin M; Katsumura Y; Hata K; Muroya Y; Nakagawa K
    J Photochem Photobiol B; 2007 Nov; 89(1):36-43. PubMed ID: 17822914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulse radiolysis study on free radical scavenger edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one). 2: A comparative study on edaravone derivatives.
    Hata K; Lin M; Katsumura Y; Muroya Y; Fu H; Yamashita S; Nakagawa H
    J Radiat Res; 2011; 52(1):15-23. PubMed ID: 21139328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New series of antiprion compounds: pyrazolone derivatives have the potent activity of inhibiting protease-resistant prion protein accumulation.
    Kimata A; Nakagawa H; Ohyama R; Fukuuchi T; Ohta S; Doh-ura K; Suzuki T; Miyata N
    J Med Chem; 2007 Oct; 50(21):5053-6. PubMed ID: 17850126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multiple free-radical scavenging (MULTIS) study on the antioxidant capacity of a neuroprotective drug, edaravone as compared with uric acid, glutathione, and trolox.
    Kamogawa E; Sueishi Y
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1376-9. PubMed ID: 24507926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the outstanding antioxidant capacity of edaravone derivatives through single electron transfer reactions.
    Pérez-González A; Galano A
    J Phys Chem B; 2012 Jan; 116(3):1180-8. PubMed ID: 22188613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A theoretical investigation on DPPH radical-scavenging mechanism of edaravone.
    Wang LF; Zhang HY
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3789-92. PubMed ID: 14552780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical repair activity of free radical scavenger edaravone: reduction reactions with dGMP hydroxyl radical adducts and suppression of base lesions and AP sites on irradiated plasmid DNA.
    Hata K; Urushibara A; Yamashita S; Lin M; Muroya Y; Shikazono N; Yokoya A; Fu H; Katsumura Y
    J Radiat Res; 2015 Jan; 56(1):59-66. PubMed ID: 25212600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo.
    Inokuchi Y; Imai S; Nakajima Y; Shimazawa M; Aihara M; Araie M; Hara H
    J Pharmacol Exp Ther; 2009 May; 329(2):687-98. PubMed ID: 19201991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The radical scavenger edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one) reacts with a pterin derivative and produces a cytotoxic substance that induces intracellular reactive oxygen species generation and cell death.
    Arai T; Nonogawa M; Makino K; Endo N; Mori H; Miyoshi T; Yamashita K; Sasada M; Kakuyama M; Fukuda K
    J Pharmacol Exp Ther; 2008 Feb; 324(2):529-38. PubMed ID: 18029546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free-radical scavenging capacity using the fenton reaction with rhodamine B as the spectrophotometric indicator.
    Yu F; Xu D; Lei R; Li N; Li K
    J Agric Food Chem; 2008 Feb; 56(3):730-5. PubMed ID: 18189354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of scavenging activity of sorghum pigment to hydroxyl free radicals by fluorimetry].
    Zhang HR; Wang WY
    Guang Pu Xue Yu Guang Pu Fen Xi; 2007 Mar; 27(3):547-51. PubMed ID: 17554919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of silybin and 2,3-dehydrosilybin antiradical activity--role of individual hydroxyl groups.
    Gazák R; Sedmera P; Vrbacký M; Vostálová J; Drahota Z; Marhol P; Walterová D; Kren V
    Free Radic Biol Med; 2009 Mar; 46(6):745-58. PubMed ID: 19138735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antioxidant activity of 2-(4(or 2)-hydroxyl-5-chloride-1,3-benzene-di-sulfanimide)-chitosan.
    Zhong Z; Xing R; Liu S; Wang L; Cai S; Li P
    Eur J Med Chem; 2008 Oct; 43(10):2171-7. PubMed ID: 18063226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyl radical scavenging assay of phenolics and flavonoids with a modified cupric reducing antioxidant capacity (CUPRAC) method using catalase for hydrogen peroxide degradation.
    Ozyürek M; Bektaşoğlu B; Güçlü K; Apak R
    Anal Chim Acta; 2008 Jun; 616(2):196-206. PubMed ID: 18482604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and evaluation of antioxidant activity of some amido-carbonyl oxime derivatives and their radical scavenging activities.
    Ozen T; Taş M
    J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1141-7. PubMed ID: 19772487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyl radical scavenging activities of isoquinoline alkaloids isolated from Coptis chinensis.
    Jang MH; Kim HY; Kang KS; Yokozawa T; Park JH
    Arch Pharm Res; 2009 Mar; 32(3):341-5. PubMed ID: 19387576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.